Biodexa Pharmaceuticals
2 clinical trials · Sponsor
◉ Watch Biodexa Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma (NCT05324501) | Biodexa Pharmaceuticals | 2022-10-19 |
| Expanded Access to 0.5 mg eRapa for Familial Adenomatous Polyposis (NCT07689942) | Biodexa Pharmaceuticals |
Track Biodexa Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.